News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,144 signal articles · 107 in last 24h · 178,660 total before filter · latest 1h ago

107last 24h

3127last 7d

512● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1821 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: HALOSentiment:bullish neutral bearish show all (incl. clickbait)

Zacks94d agoneutral

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

HALO

StockStory94d agobullish

Halozyme Therapeutics (NASDAQ:HALO) Beats Expectations in Strong Q2 CY2026, Guides for Strong Full-Year Sales

HALO

Investor's Business Daily102d agobullish

This Medical Technology Stock Claws Back To A Buy Zone

HALO

Investor's Business Daily107d agoneutral

Four Stocks Hit New Highs Amid Tech Meltdown

HALO PM

Zacks151d agoneutral

Halozyme Therapeutics (HALO) Up 0.8% Since Last Earnings Report: Can It Continue?

HALO

StockStory179d agoneutral

Halozyme Therapeutics Earnings: What To Look For From HALO

HALO

GuruFocus.com180d agoneutral

Halozyme Therapeutics Inc (HALO) Q1 2026 Earnings Call Highlights: Record Revenue Growth and ...

HALO

MarketBeat181d agoneutral

Halozyme Therapeutics Q1 Earnings Call Highlights

HALO

Zacks181d agoneutral

Halozyme Therapeutics (HALO) Reports Q1 Earnings: What Key Metrics Have to Say

HALO

Zacks181d agoneutral

Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates

HALO

Zacks185d agobullish

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

HALO IBRX

Zacks186d agoneutral

Halozyme Therapeutics (HALO) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

HALO

MarketBeat187d agoneutral

Halozyme Therapeutics AGM: Shareholders Elect Directors as CEO Torley Raises 2026 Guidance

HALO

Zacks194d agoneutral

Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Q1 Release

HALO